Stock listing

TWSE:1783 Maxigen Biotech Inc. (和康生) 股價

Follow Maxigen Biotech Inc. into a list and get an email when it puts out news.

Share price · TWSE:1783

$31.80 TWD -3.50 (-9.9%)

Close on Nov 20, 2026

Past year -25.4% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$31.60 – $34.10 TWDNov 20, 2026
Volume
172,217 sharesNov 20, 2026
Market cap
$2.85B TWDAt the close on Nov 20, 2026 · price × 89.70M shares outstanding
52-week range
$31.60 – $48.30 TWDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$2.53M TWDMedian day 58,553 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
Maxigen Biotech Inc. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TWSE:1783 · TWD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$31.80-3.50-9.9%$33.80$34.10$31.60172,217
$35.30+0.05+0.1%$35.55$35.55$34.5046,082
$35.25+0.25+0.7%$34.95$35.50$34.6055,900
$35.00-1.00-2.8%$35.65$35.65$34.9042,115
$36.00+0.20+0.6%$36.10$36.40$35.4560,218
$35.80-0.20-0.6%$37.00$37.00$35.8078,516
$36.00+0.75+2.1%$35.80$36.15$35.5599,240
$35.250.000.0%$35.45$35.45$34.8069,256
$35.25+0.55+1.6%$34.70$35.35$34.7094,360
$34.70-0.50-1.4%$34.30$35.40$33.50121,262
$35.20-0.15-0.4%$35.70$35.70$34.9033,140
$35.35+0.40+1.1%$35.30$35.40$34.8062,300
$34.95-0.05-0.1%$35.00$35.15$34.6044,652
$35.00-0.10-0.3%$35.60$35.70$34.90109,147
$35.10-1.00-2.8%$36.05$36.05$35.10115,121
$36.10-0.50-1.4%$36.55$36.55$35.70241,272
$36.60+0.30+0.8%$36.25$36.60$36.2535,333
$36.30-0.10-0.3%$36.30$36.40$36.2036,551
$36.400.000.0%$36.40$36.40$36.400
$36.40+0.10+0.3%$36.40$36.50$36.1075,400
$36.30-0.10-0.3%$36.50$37.20$36.2568,221
$36.40-0.60-1.6%$36.80$36.80$35.85122,353
$37.00-0.50-1.3%$37.50$37.50$37.0044,916
$37.50+0.10+0.3%$37.50$38.50$37.50108,691
$37.40-0.30-0.8%$37.60$37.75$37.3546,000
$37.70-0.10-0.3%$38.00$38.00$37.4563,056
$37.80-0.35-0.9%$38.05$38.10$37.2052,227
$38.15+0.05+0.1%$38.10$38.25$38.0029,000
$38.10-0.45-1.2%$38.55$38.70$38.05108,053
$38.55-0.05-0.1%$38.55$38.60$38.25100,105
$38.60+1.70+4.6%$37.90$38.75$37.5092,051
$36.90-0.15-0.4%$37.05$37.15$36.7032,381
$37.05-0.30-0.8%$36.80$37.25$36.8020,069
$37.35+0.10+0.3%$36.90$37.35$36.9043,000
$37.25+0.60+1.6%$37.05$37.25$36.8071,554
$36.65-0.05-0.1%$36.45$37.00$36.4525,010
$36.70+0.10+0.3%$36.60$36.75$36.4519,001
$36.60+0.20+0.5%$36.40$36.75$36.3054,831
$36.40-0.10-0.3%$36.55$36.55$36.1054,315
$36.50-0.20-0.5%$36.75$36.75$36.4063,014
$36.70+0.40+1.1%$36.40$36.70$36.30100,001
$36.30+0.05+0.1%$36.30$36.40$36.2035,100
$36.25+0.05+0.1%$36.25$36.30$36.1534,351
$36.20-0.20-0.5%$36.50$36.50$36.2056,050
$36.400.000.0%$36.45$36.55$36.3099,000
$36.40-0.65-1.8%$36.40$36.65$36.3559,107
$37.05-0.55-1.5%$37.55$37.60$37.00117,079
$37.60-0.20-0.5%$37.80$37.85$37.5559,105
$37.80-0.25-0.7%$38.00$38.00$37.8032,278
$38.05-0.25-0.7%$39.00$39.00$38.0079,107
$38.30-0.50-1.3%$38.65$38.95$38.3071,119
$38.80-0.30-0.8%$39.05$39.45$38.8032,148
$39.10-0.60-1.5%$39.70$39.70$39.0090,001
$39.70-1.65-4.0%$39.35$39.95$39.3598,000
$41.35+0.65+1.6%$41.50$41.50$40.60151,560
$40.700.000.0%$40.90$40.90$40.4056,256
$40.70+0.15+0.4%$40.90$40.90$40.4054,250
$40.55+0.15+0.4%$40.30$40.70$40.1053,000
$40.40+0.05+0.1%$40.35$40.40$40.1026,160
$40.35-0.05-0.1%$40.45$40.45$40.0558,000
$40.40-0.10-0.2%$40.30$40.40$40.1528,000
$40.50-0.40-1.0%$41.05$41.05$40.5052,000

Splits

1 split · TWSE:1783 · every price before a split is adjusted for it

DayRatioWhat
11-for-10Split
Ticker
TWSE:1783
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
TWSE
Currency
TWD

Latest news

All Maxigen Biotech Inc. news

Maxigen Biotech Inc. on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
12 in all · newest Aug 9, 2022 · oldest 2022

Valuation

P/E 9.8× against a median of 23.0×: 2nd lowest of 5 Medical devices & supplies companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$1.96B TWD
P/E
9.8×
EV/sales
2.3×
EV/EBITDA
6.7×
Price/book
1.9×
Gross margin
69.9%
Operating margin
30.4%
Net margin
34.8%
Debt to equity
0.1×
Beta
No index for this market yet

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Maxigen Biotech Inc. · TWSE:1783US$86.53MUS$59.38M9.8×2.3×6.7×1.9×34.8%0.1×n/a
Stereotaxis, Inc. · AMEX:STXSUS$94.41MUS$92.90Mn/a3.0×n/a4.4×−70.9%0.1×1.03
Gaush Meditech Ltd. · HKEX:2407US$94.33MUS$101.0M6.5×0.5×3.2×0.4×7.0%0.2×n/a
SciVision Biotech Inc. · TWSE:1786US$88.98MUS$76.24M16.5×2.8×10.7×1.6×20.0%0.3×n/a
Owlet, Inc. · NYSE:OWLTUS$87.58MUS$66.96Mn/a0.6×n/a3.3×−10.2%0.4×2.11
EMvision Medical Devices Ltd. · ASX:EMVUS$87.37MUS$78.30Mn/an/an/a8.4×n/a0.2×n/a
Viromed Medical AG · XETR:VMEUS$83.96MUS$83.66M127×15.0×n/a8.1×11.9%0.0×n/a
ICARES Medicus Inc · TPEX:6612US$83.86MUS$61.27M29.6×1.7×7.3×1.5×7.7%0.0×n/a
Nyxoah SA · EURONEXT:NYXHUS$83.60MUS$6.53Mn/a0.3×n/a0.9×−443.2%0.3×n/a
Optiscan Imaging Limited · ASX:OILUS$83.05MUS$74.44Mn/a251×n/a6.6×n/a0.1×n/a
EBR Systems, Inc. · ASX:EBRUS$79.78MUS$36.17Mn/an/an/a1.0×n/a0.5×n/a
Median of the othersUS$85.66MUS$75.34M23.0×2.3×7.3×2.5×7.0%0.2×1.57

Team and board

DirectorRole
Vincent LinChairman of the Board
Yung-Hsiang LinChairman
Chen-Chen FuDirector
Ching-Ting ChenDirector
Cong-Jie QiuDirector
Shih-Ming LaiDirector
Shih-Ming LiIndependent Director
Sung-Yuan LiaoIndependent Director
Tsiu-Yuan LiDirector
Zhong-Ming ZengIndependent Director

Events

QuarterResultsShare move
Q1 2023May 3, 2023 · Before open−2.3%
Q4 2022Mar 23, 2023 · Before open+2.2%
Q3 2022Oct 25, 2022 · Before open−0.9%
Q2 2022Aug 3, 2022 · After close+0.1%
Q1 2022May 3, 2022 · After close−2.1%
Q4 2021Mar 21, 2022 · Before open+3.3%
Q3 2021Nov 3, 2021 · Before open0.0%
Quarter to Jun 30, 2021Jul 27, 2021 · Before open+4.8%
Quarter to Mar 31, 2021May 14, 2021 · Before open−5.7%
Quarter to Dec 31, 2020Mar 22, 2021 · After close+9.9%

Open Events

Financials

Annual, in TWD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue811.6M680.7M622.1M604.4M512.0M457.7M452.2M427.7M427.6M336.4M
Cost of revenue247.8M197.3M198.0M230.4M250.9M243.2M234.9M245.1M267.3M201.5M
Gross profit563.7M483.3M424.1M374.0M261.0M214.5M217.3M182.6M160.3M134.9M
Research and development126.1M111.8M68.6M99.6M75.7M69.2M66.9M50.7M43.3M36.3M
Selling, general and administrative183.9M82.2M72.6M63.0M52.8M50.2M44.6M44.9M46.9M60.4M
Operating income261.0M194.4M149.8M170.6M100.7M76.9M76.1M46.1M21.0M-11.3M
Depreciation and amortization32.1M27.0M27.6M29.6M32.9M33.2M32.5M26.2M25.8M18.1M
EBITDA293.2M221.4M177.5M200.1M133.6M110.1M108.6M72.4M46.8M6.80M
Interest expense43.0K0068.0K196.0K250.0K3.43M4.02M4.12M4.81M
Income before tax304.9M225.5M193.1M165.8M97.5M76.7M72.8M57.3M16.7M-12.0M
Income tax39.6M35.4M27.3M26.4M9.80M13.4M12.7M253.0K908.0K288.0K
Net income265.3M190.2M165.8M139.4M87.7M63.3M60.1M57.1M15.8M-12.2M
Earnings per share, basic2.962.121.851.561.040.790.680.670.21-0.16

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents576.2M639.1M431.1M790.9M513.3M209.8M267.6M184.8M182.2M96.6M
Short-term investments301.5M1.50M1.50M10.3M26.9M13.1M165.0M232.3M123.0M258.1M
Receivables132.2M103.9M97.1M100.1M114.4M100.3M97.8M86.5M126.1M110.3M
Inventory99.2M75.7M85.2M75.3M79.0M87.0M88.1M82.6M94.0M91.0M
Current assets1.12B830.3M619.6M993.2M783.6M432.1M640.2M599.5M585.1M574.0M
Property, plant and equipment434.6M465.5M481.5M502.1M494.0M502.0M503.2M
Goodwill1
Total assets1.89B1.58B1.49B1.45B1.27B956.5M1.19B1.14B1.10B1.10B
Accounts payable86.8M50.0M17.1M35.9M40.1M33.0M34.0M31.0M40.5M33.8M
Current liabilities349.1M205.9M131.4M151.5M116.1M86.6M321.9M292.4M83.0M87.7M
Long-term debt013.2M14.9M
Total debt101.4M50.0K9.74M12.1M14.7M213.2M14.9M16.5M
Total liabilities355.5M207.4M131.9M152.1M123.5M96.2M334.2M292.5M307.7M316.0M
Shareholders' equity1.54B1.38B1.36B1.30B1.14B860.2M851.3M843.0M796.3M781.4M
Shares outstanding89.6M89.7M89.5M89.4M84.1M80.6M87.8M85.3M76.5M76.8M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations290.2M298.2M171.2M268.3M117.6M74.4M94.4M170.6M41.2M34.7M
Capital spending-82.6M-31.8M-22.4M-14.4M-15.4M-11.3M-23.7M-20.2M-29.0M-72.7M
Free cash flow207.6M266.5M148.8M253.9M102.1M63.1M70.7M150.4M12.2M-38.0M
Cash from investing-383.0M-29.1M-490.2M10.4M-2.77M139.1M42.6M-142.3M50.3M-141.8M
Cash from financing30.7M-59.7M-41.4M-1.05M188.7M-271.4M-54.4M-25.7M-5.28M-86.0M
Dividends paid-74.4M-89.0M-42.4M-56.3M-54.2M-51.9M-10.8M-10.8M-10.8M
Share buybacks-100.0K0-33.1M
Change in cash-62.9M208.0M-359.9M277.6M303.5M-57.9M82.8M2.63M85.6M-196.0M

Open Financials

Cap table

Built by 6ix from Maxigen Biotech Inc.’s releases

Common shares
89,698,000
Fully diluted
89,698,000

Fully diluted

LineShares
Common shares89,698,000

Share count over time

CountShares
Nov 22, 202689,698,000

Open Cap table

Shareholders

Register

HolderSharesOf the companyAs of
大江生醫股份有限公司28M31.2%Oct 31, 2026
台塑生醫科技股份有限公司8.7M9.7%Oct 31, 2026
中加投資發展股份有限公司1.38M1.5%Oct 31, 2026
林詠翔588K0.66%Oct 31, 2026
陳敬亭146K0.16%Oct 31, 2026
賴柏宏85,9970.10%Oct 31, 2026
林欣榮00.00%Oct 31, 2026
吳瑞益00.00%Oct 31, 2026
曾仲銘00.00%Oct 31, 2026
李啟睿00.00%Oct 31, 2026
All 16 holders
HolderSharesOf the companyAs of
陳適安00.00%Oct 31, 2026
廖松淵00.00%Oct 31, 2026
賴世明00.00%Oct 31, 2026
黃振嘉00.00%Oct 31, 2026
李秋月00.00%Oct 31, 2026
大江生醫股份有限公司Nov 22, 2026

Funds

HolderSharesValueAs of
Emerging Markets Core Equity 2 Portfolio219KUS$269KJul 31, 2026
Dimensional Emerging Markets Core Equity 2 ETF57,000US$70,282Jul 31, 2026
The Emerging Markets Small Cap Series48,600US$59,877Jul 31, 2026
Dimensional World ex. U.S. Core Equity 2 ETF36,000US$44,389Jul 31, 2026
World ex U.S. Core Equity Portfolio18,000US$22,177Jul 31, 2026
Dimensional Emerging Core Equity Market ETF14,700US$18,125Jul 31, 2026
Emerging Markets Social Core Equity Portfolio13,650US$16,817Jul 31, 2026
Emerging Markets ex China Core Equity Portfolio3,000US$3,696Jul 31, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Chen-Chen FuDirector · Since at least Nov 5, 2026
Ching-Ting ChenDirector · Since at least Nov 5, 2026
Cong-Jie QiuDirector · Since at least Nov 5, 2026
Shih-Ming LaiDirector · Since at least Nov 5, 2026
Shih-Ming LiIndependent Director · Since at least Nov 5, 2026
Sung-Yuan LiaoIndependent Director · Since at least Nov 5, 2026
Tsiu-Yuan LiDirector · Since at least Nov 5, 2026
Vincent LinChairman of the Board · Since at least Nov 5, 2026
Yung-Hsiang LinChairman · Since at least Nov 5, 2026
Zhong-Ming ZengIndependent Director · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Maxigen Biotech Inc.